Enzo Biochem Receives Emergency Use Authorization for Proprietary Test System for Detection of Coronavirus SARS-CoV-2
13 juil. 2020 08h30 HE
|
Enzo Biochem, Inc.
Flexible Use on Three Platforms including Enzo’s Proprietary Automated GENFLEX™ Platform NEW YORK, NY, July 13, 2020 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and...
Enzo Biochem to Provide COVID-19 Testing to Farmingdale State College Staff and Students as They Return to Campus
30 juin 2020 13h15 HE
|
Enzo Biochem, Inc.
First Collaboration under Enzo’s School and Institution Testing (“SIT”) Program NEW YORK, NY, June 30, 2020 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and...
Enzo Announces Issuance of U.S. Patent for Methods of Treating Liver Cancer Using Proprietary Compound SK1-I
23 juin 2020 08h30 HE
|
Enzo Biochem, Inc.
Continues to Explore Opportunities for Use of the Compound as a Potential Treatment for COVID-19 NEW YORK, NY, June 23, 2020 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ), a leading...
Enzo Biochem Reports Third Quarter 2020 Financial Results
08 juin 2020 16h05 HE
|
Enzo Biochem, Inc.
Revenue of $17 million and EPS of ($0.21) due to COVID-19 impactAchieved major milestone with launch of comprehensive COVID-19 program for virus screening and antibody testing NEW YORK, June 08,...
Enzo Biochem to Announce Third Quarter 2020 Financial Results on Monday June 8, 2020
03 juin 2020 16h05 HE
|
Enzo Biochem, Inc.
NEW YORK, NY, June 03, 2020 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) a leading biosciences and diagnostics company, today announced that it will release its third quarter 2020 financial...
Enzo Biochem Launches Proprietary Test for Detection of Coronavirus SARS-CoV-2 IgG Antibody Under FDA’s Emergency Use Authorization
20 mai 2020 08h00 HE
|
Enzo Biochem, Inc.
Second Product Offering to Expand Disease Management within Enzo’s Comprehensive COVID-19 Program Enzo’s ELISA Kit for SARS-CoV-2 IgG Antibody Demonstrates High Specificity and High Sensitivity...
Enzo Announces Issuance of U.S. Patent for Methods of Producing Monoclonal Antibodies Against Osteoporosis Drug Target Sclerostin
12 mai 2020 08h00 HE
|
Enzo Biochem, Inc.
NEW YORK, NY, May 12, 2020 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) a leading biosciences and diagnostics company, today announced the recent issuance of U.S. Patent No. 10,626,170...
Enzo Announces Issuance of U.S. Patent for Methods of Using Proprietary Compound SK1-I in Patients; Exploring Options for Development as a Potential Treatment for COVID-19
29 avr. 2020 08h00 HE
|
Enzo Biochem, Inc.
NEW YORK, NY, April 29, 2020 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ), a leading biosciences and diagnostics company, today announced the recent issuance of U.S. Patent No. 10,624,863...